Friedenwald Award winner highlights over 30 years of understanding, treating glaucoma

Spanning a career over 30 years in glaucoma service and research, HarryA. Quigley, MD, provided an overview of the progress made in treating thedisease throughout his 2004 Friedenwald Award lecture, entitled "Glaucoma:From Macrocosm to Microcosm."

Related Videos

Related Content

Advertisement

March 14th 2025

Survey reveals gaps in patient awareness of preservative-free glaucoma treatments

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 13th 2025

Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 12th 2025

Choroidal vascularity index offers insight into eye health after COVID-19 recovery

March 11th 2025

FDA accepts new drug application for low-dose atropine from Sydnexis

Related Content

Advertisement

March 14th 2025

Survey reveals gaps in patient awareness of preservative-free glaucoma treatments

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 13th 2025

Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 12th 2025

Choroidal vascularity index offers insight into eye health after COVID-19 recovery

March 11th 2025

FDA accepts new drug application for low-dose atropine from Sydnexis